BWAM
TSVT

Boyd Watterson Asset Management’s 2seventy bio TSVT Stock Holding History

Boyd Watterson Asset Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-41
Closed -$175 – 447
2023
Q4 		$175 Hold
41
– – ﹤0.01% 418
2023
Q3 		$161 Hold
41
– – ﹤0.01% 416
2023
Q2 		$415 Hold
41
– – ﹤0.01% 408
2023
Q1 		$418 Hold
41
– – ﹤0.01% 409
2022
Q4 		$384 Buy
+41
New +$578 ﹤0.01% 413

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Boyd Watterson Asset Management's TSVT Position: Q1 2024 in Review

Boyd Watterson Asset Management sold out of 2seventy bio (TSVT) in Q1 2024, closing a stake of 41 shares — an estimated $175 sold.

Boyd Watterson Asset Management first reported a position in TSVT in Q4 2022 and held it in 5 quarters. The position peaked at $418 in Q1 2023. 117 funds tracked by Wall St. Rank hold TSVT as of Q1 2024.

  • Boyd Watterson Asset Management reported no remaining 2seventy bio position as of Q1 2024 after selling out during the quarter.
  • Boyd Watterson Asset Management sold 41 2seventy bio shares in Q1 2024, an estimated $175.
  • Boyd Watterson Asset Management first reported a position in 2seventy bio in Q4 2022 and held it in 5 quarters.
  • Boyd Watterson Asset Management's 2seventy bio position peaked at $418 in Q1 2023.
  • 117 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2024.

Based on Boyd Watterson Asset Management's 13F filing for Q1 2024, filed 29 Apr 2024.